From the Guidelines
The elevated hemoglobin of 158, increased white blood cell count of 13.5, and elevated platelets of 436 suggest a possible myeloproliferative disorder, particularly polycythemia vera, and warrant further investigation with additional blood tests, including JAK2 mutation analysis, erythropoietin levels, and bone marrow examination if indicated, as recommended by the European LeukemiaNet criteria 1. The findings of elevated hemoglobin, white blood cell count, and platelets can increase blood viscosity and thrombosis risk, as the overproduction of blood cells is either due to autonomous bone marrow proliferation (primary) or a response to underlying conditions like hypoxia, inflammation, or malignancy (secondary) 2. Some key points to consider in the management of these findings include:
- Maintaining adequate hydration to reduce blood viscosity
- Considering low-dose aspirin (81-100mg daily) to reduce thrombotic risk after consultation with a hematologist, as the risk of thrombosis is increased in patients with myeloproliferative disorders, particularly those with polycythemia vera 2
- Smoking cessation, if applicable, to reduce cardiovascular risk
- Prompt hematology referral for definitive diagnosis and management, as treatment approaches differ significantly between primary myeloproliferative disorders and reactive causes The most recent and highest quality study, published in 2021, highlights the importance of considering thrombotic risk in patients with myeloproliferative disorders, particularly those with polycythemia vera, and recommends a thorough evaluation of risk factors, including age, prior thrombosis, and leukocytosis 2.
From the Research
Clinical Significance of Elevated Haemoglobin and White Blood Cell Count
- Elevated haemoglobin levels (158) above the normal range (147) may indicate dehydration, polycythemia, or other underlying conditions 3.
- An elevated white blood cell count (13.5) above the normal range (9.4) can be caused by various factors, including infections, inflammatory processes, physical or emotional stress, or primary bone marrow disorders 4.
- The combination of elevated haemoglobin and white blood cell count may suggest an underlying condition that requires further investigation, such as acute coronary syndrome, where hematological indices play a key role in pathophysiology and risk stratification 5.
Platelet Count
- An elevated platelet count (436) above the normal range (372) can be associated with various conditions, including inflammation, infection, or primary bone marrow disorders 3.
- Platelet indices, such as platelet to lymphocyte ratio (PLR), mean platelet volume (MPV), and platelet distribution width (PDW), can provide additional information on the underlying condition and risk stratification in patients with acute coronary syndrome 5.
Potential Underlying Conditions
- Primary bone marrow disorders, such as acute or chronic leukemias, or myeloproliferative disorders, should be suspected in patients with extremely elevated white blood cell counts or concurrent abnormalities in red blood cell or platelet counts 4.
- Acute coronary syndrome, which is associated with increased systemic and local inflammation, may be a potential underlying condition, and hematological indices can provide valuable information on risk stratification and optimal management 5.